Cas no 1250038-86-8 (6-tert-butyl-2-methylpyrimidin-4-amine)
6-tert-butyl-2-methylpyrimidin-4-amine Chemical and Physical Properties
Names and Identifiers
-
- 6-tert-butyl-2-methylpyrimidin-4-amine
- 6-(tert-Butyl)-2-methylpyrimidin-4-amine
- 6-tert-Butyl-2-methyl-pyrimidin-4-ylamine
- DB-325566
- DTXSID90696294
- SB32203
- 6-t-Butyl-2-methyl-pyrimidin-4-ylamine
- 1250038-86-8
- MFCD16103590
- AKOS011055484
- CS-0334741
- SCHEMBL2718887
- F1967-7058
-
- MDL: MFCD16103590
- Inchi: 1S/C9H15N3/c1-6-11-7(9(2,3)4)5-8(10)12-6/h5H,1-4H3,(H2,10,11,12)
- InChI Key: BVVMZMZUCSUOTK-UHFFFAOYSA-N
- SMILES: N1C(C)=NC(=CC=1C(C)(C)C)N
Computed Properties
- Exact Mass: 165.126597491g/mol
- Monoisotopic Mass: 165.126597491g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 12
- Rotatable Bond Count: 1
- Complexity: 150
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.7
- Topological Polar Surface Area: 51.8?2
6-tert-butyl-2-methylpyrimidin-4-amine Security Information
- Signal Word:warning
- Hazard Statement: H303+H313+H333
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
6-tert-butyl-2-methylpyrimidin-4-amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A089004932-1g |
6-(tert-Butyl)-2-methylpyrimidin-4-amine |
1250038-86-8 | 95% | 1g |
$400.00 | 2023-09-03 | |
| TRC | B812720-10mg |
6-tert-Butyl-2-methyl-pyrimidin-4-ylamine |
1250038-86-8 | 10mg |
$ 50.00 | 2022-06-06 | ||
| TRC | B812720-50mg |
6-tert-Butyl-2-methyl-pyrimidin-4-ylamine |
1250038-86-8 | 50mg |
$ 115.00 | 2022-06-06 | ||
| TRC | B812720-100mg |
6-tert-Butyl-2-methyl-pyrimidin-4-ylamine |
1250038-86-8 | 100mg |
$ 185.00 | 2022-06-06 | ||
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 70R0228-1g |
6-tert-Butyl-2-methyl-pyrimidin-4-ylamine |
1250038-86-8 | 98% | 1g |
8463.46CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 70R0228-5g |
6-tert-Butyl-2-methyl-pyrimidin-4-ylamine |
1250038-86-8 | 98% | 5g |
33904.74CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 70R0228-500mg |
6-tert-Butyl-2-methyl-pyrimidin-4-ylamine |
1250038-86-8 | 98% | 500mg |
4655.75CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 70R0228-250mg |
6-tert-Butyl-2-methyl-pyrimidin-4-ylamine |
1250038-86-8 | 98% | 250mg |
2756.14CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 70R0228-100mg |
6-tert-Butyl-2-methyl-pyrimidin-4-ylamine |
1250038-86-8 | 98% | 100mg |
1797.85CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 70R0228-50mg |
6-tert-Butyl-2-methyl-pyrimidin-4-ylamine |
1250038-86-8 | 98% | 50mg |
1322.95CNY | 2021-05-08 |
6-tert-butyl-2-methylpyrimidin-4-amine Related Literature
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
Additional information on 6-tert-butyl-2-methylpyrimidin-4-amine
Introduction to 6-tert-butyl-2-methylpyrimidin-4-amine (CAS No. 1250038-86-8)
6-tert-butyl-2-methylpyrimidin-4-amine, identified by its Chemical Abstracts Service (CAS) number 1250038-86-8, is a significant compound in the realm of pharmaceutical and agrochemical research. This heterocyclic amine derivative has garnered attention due to its structural uniqueness and potential applications in drug development. The presence of a tert-butyl group at the 6-position and a methyl group at the 2-position contributes to its distinct chemical properties, making it a valuable candidate for further exploration.
The compound belongs to the pyrimidine family, a class of nitrogen-containing heterocycles that are widely recognized for their biological activity. Pyrimidines are fundamental components of nucleic acids, and derivatives of these molecules have been extensively studied for their pharmacological effects. The specific substitution pattern in 6-tert-butyl-2-methylpyrimidin-4-amine suggests potential interactions with biological targets, which could be exploited for therapeutic purposes.
In recent years, there has been a surge in research focused on developing novel pyrimidine-based compounds with enhanced efficacy and reduced side effects. The 6-tert-butyl-2-methylpyrimidin-4-amine structure presents an intriguing platform for such modifications. Its bulky tert-butyl group can influence the compound's solubility and metabolic stability, while the methyl group may affect binding affinity to biological targets. These features make it a promising scaffold for designing next-generation pharmaceuticals.
One of the most compelling aspects of this compound is its potential role in addressing unmet medical needs. Current research indicates that pyrimidine derivatives are effective in various therapeutic areas, including oncology, antiviral, and anti-inflammatory treatments. The 6-tert-butyl-2-methylpyrimidin-4-amine molecule, with its unique structural features, could serve as a lead compound for generating libraries of derivatives through combinatorial chemistry or structure-based drug design.
Recent advancements in computational chemistry have enabled researchers to predict the biological activity of small molecules with remarkable accuracy. By leveraging molecular docking simulations and quantum mechanical calculations, scientists can identify how 6-tert-butyl-2-methylpyrimidin-4-amine interacts with biological targets such as enzymes or receptors. These insights are crucial for optimizing the compound's pharmacokinetic and pharmacodynamic properties.
The synthesis of 6-tert-butyl-2-methylpyrimidin-4-amine involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies, including transition-metal-catalyzed cross-coupling reactions and palladium-mediated transformations, have been employed to construct the desired pyrimidine core. The introduction of the tert-butyl and methyl groups demands careful consideration to ensure regioselectivity and high yields.
In the context of drug discovery, the development of novel analogs often relies on modifications that enhance target engagement while minimizing off-target effects. The flexibility offered by the 6-tert-butyl-2-methylpyrimidin-4-amine scaffold allows for diverse chemical manipulations. For instance, replacing the amine functionality with other heteroatoms or introducing additional substituents can lead to compounds with tailored biological activities.
The agrochemical industry has also shown interest in pyrimidine derivatives due to their potential as pesticides or herbicides. The structural features of 6-tert-butyl-2-methylpyrimidin-4-amine, particularly the presence of bulky groups, may confer resistance to degradation under environmental conditions. This stability is essential for ensuring prolonged activity in agricultural applications.
As our understanding of molecular interactions evolves, so does our ability to design compounds with specific functions. The integration of artificial intelligence (AI) and machine learning (ML) into drug discovery has accelerated the identification of promising candidates like 6-tert-butyl-2-methylpyrimidin-4-am ine. These technologies can analyze vast datasets to predict which molecular modifications will yield compounds with desired properties.
The regulatory landscape for new chemical entities is stringent but necessary to ensure safety and efficacy. Companies developing derivatives of 6-tert-butyl-2-methylpyrimidin -4-am ine must navigate rigorous preclinical and clinical testing before reaching market approval. However, the potential benefits justify these efforts, especially when addressing critical unmet medical needs.
In conclusion,6 - tert-butyl - 2 - methylpyrimidin - 4 - am ine (CAS No. 1250038 - 86 - 8) represents a fascinating compound with broad applications in pharmaceuticals and agrochemicals. Its unique structural features position it as a valuable scaffold for further research and development. As scientific methodologies continue to advance, we can expect more discoveries stemming from this versatile molecule.
1250038-86-8 (6-tert-butyl-2-methylpyrimidin-4-amine) Related Products
- 3435-27-6(6-tert-butylpyrimidin-4-amine)
- 175137-26-5(6-(tert-Butyl)pyrimidine-2,4-diamine)
- 95206-97-6(2-methyl-6-(propan-2-yl)pyrimidin-4-amine)
- 4595-70-4(6-methyl-2-(propan-2-yl)pyrimidin-4-amine)
- 1249629-26-2(2,6-diisopropylpyrimidin-4-amine)
- 1247386-17-9(2-Ethyl-6-isopropylpyrimidin-4-amine)
- 90008-43-8(6-ethyl-2-methylpyrimidin-4-amine)
- 785020-52-2(2,6-Diethylpyrimidin-4-amine)
- 1159818-06-0(6-(propan-2-yl)pyrimidin-4-amine)
- 1250621-57-8(2-Tert-butyl-6-methyl-pyrimidin-4-ylamine)